Splicing Factor SF3A Plays A Crucial Role in Gene Splicing and Tumorigenesis

Target Name: Splicing factor 3A protein complex

NCBI ID: P17061

Splicing factor 3A protein complex

Other Name(s): Splicing factor SF3A | SF3A

Splicing Factor SF3A Plays A Crucial Role in Gene Splicing and Tumorigenesis

Splicing factor 3A protein complex (Splicing factor SF3A) is a protein that plays a crucial role in the process of gene splicing. Gene splicing is the process by which the DNA code in a cell is turned into the proteins that make up the cell. This process is essential for the development and maintenance of a cell's genetic identity, as well as for the production of proteins that are unique to each cell.

The Splicing factor SF3A protein complex is a protein that is composed of several subunits that work together to ensure the proper execution of the gene splicing process. It is a protein that is expressed in most tissues of the body and is involved in the regulation of gene splicing.

One of the key functions of the Splicing factor SF3A protein complex is to recruit specific splicing factors to the nuclear kernel. The Nucleus is the primary repository of genetic material in the cell and the center of cellular metabolism and protein synthesis. The nucleolus is a complex organelle that contains many proteins involved in gene transcription. Splicing factor SF3A protein complex recruits these proteins to the nucleolus by binding to specific splicing factors, thereby ensuring normal transcription of genes.

Splicing factor SF3A protein complex is also involved in regulating RNA splicing. RNA splicing is an important gene expression process. It refers to removing some useless sequences and adding some useful sequences in the RNA molecules produced by gene transcription, making the generated RNA molecules easier to be translated into proteins. Splicing factor SF3A protein complex participates in RNA splicing by binding to specific RNA-binding proteins. These RNA-binding proteins can recognize and bind to specific sequences of RNA molecules, thereby ensuring the smooth progress of RNA splicing.

In addition, the Splicing factor SF3A protein complex is also related to the cell cycle. The cell cycle is the cyclical process of cell growth and division. Splicing factor SF3A protein complex plays an important role in the cell cycle and is involved in the separation and assembly of chromosomes in mitosis. In mitosis, the Splicing factor SF3A protein complex binds to specific regions on chromosomes, thereby ensuring smooth chromosome separation and assembly.

In addition, Splicing factor SF3A protein complex is also related to tumorigenesis. Oncogenesis is an abnormal cell proliferation process that leads to the formation of tumors. Abnormal expression of splicing factor SF3A protein complex is closely related to tumorigenesis. Studies have found that abnormal expression of the Splicing factor SF3A protein complex is a common feature of many tumors, and it may be a potential drug target or biomarker.

Splicing factor SF3A protein complex is a protein that plays an important role in gene transcription and expression. Its abnormal expression is closely related to the occurrence and development of many tumors, therefore, it may be a potential drug target or biomarker. Future studies will further explore the function of the splicing factor SF3A protein complex and investigate its application in drug development.

Protein Name: Splicing Factor 3A Protein Complex

The "Splicing factor 3A protein complex Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Splicing factor 3A protein complex comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets